Specific CAR T-cell subgroup could make lower-dose cancer therapy more effective
Immunotherapies strengthen the body's own anticancer defenses in a highly targeted manner. In therapies using so-called CAR T cells (chimeric antigen receptor T cells), a patient's immune cells are genetically engineered ...
Sep 8, 2026
0
10









